Ensuring Innovation and Competition for Biologics Leads to More Timely Products for Patients

A robust market for safe, effective biosimilar products is crucial – more products on the market increases competition which can lead to more access and reduced health care costs for patients and our nation’s health care system.

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2KKj8kA